Current Migraine News and Events | Page 18

Current Migraine News and Events, Migraine News Articles.
Sort By: Most Relevant | Most Viewed
Page 18 of 19 | 732 Results
University of Pittsburgh neurologist says migraine headaches are under-diagnosed
Migraine headaches, suffered by millions of Americans and debilitating for many, are significantly under-diagnosed by physicians, according to a University of Pittsburgh neurologist writing in the March 19 issue of the Journal of the American Medical Association. (2003-03-18)

First study to show the potential for effective prevention of migraine with an AT1 receptor blocker
New results, published in the Journal of the American Medical Association (JAMA), show the positive effect of a novel treatment in reducing the frequency of severe headaches in adults suffering from migraines. (2003-01-02)

Nation's two largest medical specialty groups issue migraine treatment guidelines
Migraine headaches can be successfully treated and in many cases prevented, say new joint clinical guidelines from the nation's two largest groups of primary care physicians. (2002-11-18)

The Lancet neurology press release
Migraine is a very common neurological disorder affecting 15% of people from western populations. However, the mechanisms that cause migraine are poorly understood. Studies of families with migraine have identified a number of genetic loci that may have some role in the development of migraine. Anne Ducros (Hopital Lariboisiere, Paris, France) and colleagues review research on the genetics of migraine, the problems with identifying genes involved, and the possible mechanisms by which mutations in genes that encode ion channels may cause the attacks. (2002-08-14)

Migraines cost employers millions in productivity, but interventions can help
Lost productivity due to migraines could be enough to give business owners their own headaches---a recent University of Michigan study pegged Bank One's annual loss due to migraines at more than $20 million. (2002-08-08)

Study finds a mouse model for episodic neurological disorders
For years, physicians have noticed surprising similarities in the factors that seem to trigger attacks in such episodic neurological disorders as migraine and dyskinesia. Common triggers include psychological stress, caffeine or alcohol ingestion, fatigue, hormonal fluctuations and exercise. A new study shows that a mouse model can be used to investigate how these substances and environmental factors trigger symptomatic attacks. The researchers also identified two drugs that can prevent attacks of such disorders in mice. (2002-08-05)

Botox proving successful at preventing headaches
Small amounts of the most deadly toxin known to man are proving effective at preventing debilitating headaches. Todd Troost, M.D., from Wake Forest University Baptist Medical Center, today reported success rates as high as 92 percent using injections of botulinum toxin to treat patients who didn't respond to headache medications. (2002-06-18)

Drugs may not be best weapon against teen migraines, study finds
A new study of migraine headaches suggests behavioral therapy ? not medication -- may be the most effective weapon against migraine pain for teen-agers. (2002-06-18)

Hebrew University student developing drug to treat epilepsy, migraines, chronic pain
Nina Isoherranen, a Ph.D. candidate at the Hebrew University School of Pharmacy, was awarded a Kaye Innovation Award this week for developing a new medication to treat epilepsy, migraine headaches, and chronic pain that does not cause birth defects in animal models, unlike other medicines currently used to treat epilepsy. (2002-06-06)

Restricting epileptic drivers unnecessary, counterproductive
An article reviewing motor vehicle crashes among epileptic drivers finds statutes requiring physicians to report epileptic patients to driver-licensing authorities both unnecessary and counterproductive. (2002-05-30)

Causes of menstrual migraine explored
A new study into the causes of menstrual migraine may bring researchers one step closer to understanding the disease that affects millions of American women. (2002-04-16)

Millions of migraine sufferers could benefit from better use of medical care
While more than 28 million U.S. adults (13 percent of the total ) suffer from migraine headaches, less than one-half are seeking medical treatment and taking advantage of the latest in prescription medications, according to a study published in the current issue of Neurology, the scientific journal of the American Academy of Neurology. (2002-03-25)

Treating eye pain may remove other migraine symptoms
Eye pain is an oft-accompanied symptom of migraine sufferers. Researchers have found that treating inflammation in the eye's trochlea tendon can relieve the headache pain associated with migraines, or prevent the triggering of full-blown migraine attacks. The study of five migraine patients with trochleitis (inflammation of the trochlea tendon) is reported in the current issue of Neurology, the scientific journal of the American Academy of Neurology. (2002-03-11)

UCLA scientists identify genetic link to migraine
UCLA geneticists have discovered the first evidence that migraine with aura is a hereditary condition. Reported in the March 1 edition of the American Journal of Human Genetics, the findings will enable researchers to isolate the gene that predisposes people to the painful disorder. (2002-02-25)

Studies suggest new headache treatment is more effective than medication
In a controlled study conducted at New York Medical College, a new headache treatment outperformed Imitrex, the most widely prescribed migraine medication. In an earlier study at the Westchester Medical Center Emergency Room, 80% of patients with extremely severe migraine or tension-type headaches, including pregnant women, were made comfortable within 40 minutes without medication. (2002-02-20)

Which triptan for migraine relief?
A meta-analysis of a class of drugs called the triptans-known to be effective for migraine relief -is detailed in this week's issue of THE LANCET. Three oral triptans-10 mg rizatriptan, 80 mg eletriptan, and 12.5 mg almotriptan-offer the best future chance of success. (2001-11-15)

Herb used to treat migraine headaches could be used to develop new anti-inflammatory drugs
Yale researchers have shown for the first time that a component of the medicinal herb feverfew targets a protein called IkappaB Kinase and halts that protein's role in the inflammation process. (2001-08-08)

Left handers at twice the risk of inflammatory bowel disease
Left handers seem to be at twice the risk of developing inflammatory bowel disease, such as Crohn's disease and ulcerative colitis, suggests research in Gut. (2001-07-11)

Application deadline extended for new AstraZeneca neurology, psychiatry awards
AstraZeneca PLC has extended the application deadline to Aug. 31, 2001 for proposal submissions for its international, peer-reviewed Young Minds in CNS Awards Program, which recognizes and promotes promising work from young physicians and investigators working in the central nervous system (CNS) therapeutic area. The program will award five US $20,000 unrestricted career development awards in October 2001 to support research, educational efforts, travel, salary and materials. (2001-03-25)

Men and women recover differently after surgery
Women emerge more quickly than men from general anaesthesia, but have a slower return to former health after surgery, according to a study in this week's BMJ. (2001-03-22)

Pharmacologist tip sheet: Migraine patches, nicotine therapies, allergy medication interference...
Nicotine Helps the Brain Stay Alert, Lidocaine Cream Can Help With Migraine Pain, Juices Interfere With Popular Allergy Medicine, Tracking Adherence to AIDS Medication Regimes (2001-03-06)

New treatment for whiplash induced headaches
Doctor's at the University of Pennsylvania's Department of Rehabilitation Medicine have demonstrated a new and successful technique for treating headaches stemming from whiplash injuires by injecting a steroid into the C2-3 joint where the skull connects to the spine. (2001-02-28)

Cutting-edge research on nicotine and mind alertness, topical migraine treatment, nursing home under treatment, and more to be presented at conference
Cutting-edge research on nicotine and mind alertness, topical migraine treatment, nursing home under treatment, aids therapies, and international drugs registry to be presented at pharmacology conference. (2001-02-27)

Gluten in the diet may be the cause of recurring headaches
It may be worthwhile to consider how much wheat you eat if you suffer from headaches or lack of coordination and have gluten sensitivity. Researchers found that removing or cutting back on gluten - a protein in wheat and other grains --in the diet greatly reduced these symptoms among a middle-aged study group. (2001-02-12)

New AstraZeneca awards program recognizes, supports future leaders in neurology and psychiatry
AstraZeneca PLC has created the AstraZeneca Young Minds in CNS Awards Program to recognize and promote promising work from young clinicians and researchers working in the central nervous system therapeutic area. Through the Program, AstraZeneca will create partnerships with neurologists and psychiatrists to enhance effectiveness of disease management and ultimately to help patients enjoy a better life. (2001-02-11)

400 never-before published findings to be presented at pharmacology conference
The nation's leading pharmacologists and researchers on the impact of drugs on the body will gather from March 6-10 at the annual meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT). (2001-02-07)

Children find relief from migraine through biofeedback and relaxation training
Relaxation training and biofeedback have proven to be promising treatments for children who suffer from migraine headaches, according to a study in the January 9 issue of Neurology, the scientific journal of the American Academy of Neurology. (2001-01-08)

Lisinopril can prevent migraine attacks
The drug Lisinopril - widely prescribed for various cardiovascular conditions - is an effective, preventive treatment for frequent migraine attacks, finds research in this week's BMJ. (2001-01-04)

Why diet drug phen/fen damaged the heart
A new study published in the December 5 issue of the American Heart Association's journal (2000-12-07)

Migraine risk highest during first two days of menstrual cycle
Women are twice as likely to experience migraine without aura during the first two days of their menstrual cycle than during the rest of the month, according to a study in the November 28 issue of Neurology, the scientific journal of the American Academy of Neurology. (2000-11-27)

Botox treatment for wrinkles may also relieve migraines
A treatment commonly used by dermatologists to get rid of facial wrinkles may also help migraine sufferers, a UCSF researcher has reported. (2000-11-13)

Research measures migraine's impact on 'typical' sufferer, links migraine and depression
The first research to examine migraine's impact on the general population shows that even 'typical' migraine sufferers consistently report lower mental, physical and social well-being than people without migraines. (2000-09-11)

Young women with heart disease at risk of 'menstrual angina'
Young women with heart disease seem to be at risk of (2000-07-25)

Cool down those hot flashes -- drug may offer relief
Gabapentin, a drug used to prevent migraines and seizures, may offer hope to the millions of women who suffer from menopausal-related hot flashes. According to a case report published in the June 13 issue of Neurology, the American Academy of Neurology's scientific journal, gabapentin may significantly reduce the frequency of hot flashes. (2000-06-12)

Biofeedback may help children with migraines
Children with migraines can significantly reduce the number, intensity, and duration of their headaches with biofeedback training, suggest the results of a small study by German researchers. (2000-05-24)

Psychologically abused women experience significant physical and mental health problems
Women experiencing psychological intimate partner violence were more likely to report poor physical and mental health than women who were not abused, according to an article in the May issue of the American Medical Association's Archives of Family Medicine, a member of the JAMA family of journals. (2000-05-13)

New understanding of migraines may lead to more effective treatments
The painfully sensitive skin that accompanies many migraines has revealed a new understanding of the debilitating headaches. The study is the first human test of a migraine model that may explain why current medications are ineffective in many cases and suggests a new target for the next generation of migraine drugs. (2000-04-26)

Practice parameter takes unified approach to diagnosis, treatment of migraines
An article published in the April 25 issue of Neurology, the American Academy of Neurology's scientific journal, encourages aggressive treatment of migraine headache, a condition affecting 28 million Americans, and refers physicians to a new set of practice guidelines being published simultaneously on the journal's Web site. (2000-04-24)

From smoking to sumatriptan, researchers present important new findings on the impacts of drug metabolism
Pharmacologists from across the country and around the world will offer more than 350 presentations during the American Society for Clinical Pharmacology and Therapeutics annual meeting March 15-18 at the Century Plaza Hotel & Tower. (2000-03-14)

Is it all in your head? No, weather can trigger migraines
Migraine sufferers can look to the sky as a possible cause for the onset of their headaches. A study in the January 25 issue of Neurology, the scientific journal of the American Academy of Neurology, found Canadian Chinook winds can trigger migraines in some people. The Chinooks are warm westerly winds specific to Alberta, Canada. (2000-01-24)

Page 18 of 19 | 732 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.